In addition, brokers have named them as buys recently and are tipping big returns over the next 12 months. Here are three ASX ...

Both of these S&P/ASX 200 Index (ASX: XJO) growth shares have compelling futures. Based on their outlook, they could be top ...

I think this is a wonderful ASX-listed exchange-traded fund (ETF) that could be a good antidote to all of the uncertainty ...

Macquarie is a fan of the company and has an outperform rating and $22.00 price target on its shares. In respect to income, ...

There are numerous options for ASX investors interested in the lithium space. Here we look at three ASX lithium shares.

Bought $10,000 of Rio Tinto Ltd (ASX: RIO) shares five years ago? Guess how much that investment is worth today!

Should you buy BHP Group Ltd (ASX: BHP) and Rio Tinto Ltd (ASX: RIO) shares? Let's see what Macquarie Group Ltd (ASX: MQG) is ...

Here are three ASX shares that could be worth snapping up before they rebound fully. Let's see why they could be top ...

ASX defence stocks like the BetaShares Global Defence ETF (ASX: ARMR) have soared this year while the markets have fallen.

ResMed shares have been caught up in the recent market volatility. Has this created a buying window for ResMed shares?

In light of the above, the broker has retained its buy rating on the ASX stock with a slightly trimmed price target of $3.00.

It’s a banner day for most S&P/ASX 200 Index (ASX: XJO) shares today. Here’s why these five are surging 11% to more than 20%.